Archive for July 20th, 2010

Scientist Consider New Option for Shutting Down Leaking Gulf Well

As integrity tests continue Tuesday on BP’s ruptured Gulf oil well, scientists are weighing a possible new option for permanently sealing it.

The “static kill” method, as it is being called, would involve pumping mud into the well to force oil back into the reservoir below, BP officials said Monday, noting that the option could succeed where other similar ones have failed because pressure in the well is lower than expected.

Read the rest of this entry »

U.S. government sues feed dealers in False Claims Act suit

It often seems that government contractor fraud against the United States is limited primarily to the fields of health care and the military.  But no.  Government contractor fraud can be found quite literally in the fields, specifically the fields of Kansas – in which state the U.S. has brought a False Claims Act lawsuit against R&J Feed Co. and Carter Livestock Inc., along with Jerry Goodwin and Richard Carter.  The suit alleges that the defendants violated the federal False Claims Act by improperly exporting nonfat dry milk owned by the U.S. Department of Agriculture (USDA) and promised to U.S. livestock producers in designated drought-ridden states.

Read the rest of this entry »

FDA prepares for advisory committee meeting about heart risks of diabetes drug Avandia

The U.S. Food and Drug Administration (FDA) will convene an advisory committee meeting next week to consider the fate of the diabetes drug Avandia, responding to mounting concerns about the heart attack and stroke risks for patients taking the drug.

A medical team leader of the agency’s Division of Cardiovascular and Renal Products recently released a 765-page briefing document, concluding that a large clinical trial of the drug—which was sponsored by manufacturer GlaxoSmithKline—“was inadequately designed and conducted to provide any reassurance” of the drug’s safety.  Among the study’s problems included the fact that patients and researchers knew who was getting which drugs, which could bias the findings; lack of complete information about the participants who died during the study; and others.

Read the rest of this entry »